Journal of Neuroendovascular Therapy
Online ISSN : 2186-2494
Print ISSN : 1882-4072
ISSN-L : 1882-4072
Review Articles
Diagnosis of Carotid Plaque Using FDG-PET
Eiichi Kobayashi
Author information

2018 Volume 12 Issue 12 Pages 622-631


Positron emission tomography (PET) with 18F-2-deoxy-2-fluoro-D-glucose (FDG) provides valuable metabolic information regarding arteriosclerotic lesions and may be applied for the detection of vulnerable plaque. When FDG, as a glucose analog, is phosphorylated in the intracytoplasmic area, its metabolism stops and remains, so-called intracellular metabolic trapping, and images are made utilizing this characteristic. Pathological examination of extirpated plaque confirmed that FDG accumulation was strongly correlated with the distribution and density of inflammatory cells, especially macrophages. Images suggestive of plaque inflammation and therefore its vulnerability were obtained. Even in patients with relatively slight stenosis, FDG accumulation was often observed; it was not always correlated with the percent stenosis, but quantitative values of FDG uptake or its changes may reflect the progression of arteriosclerosis. FDG is also utilized as a surrogate marker of drug efficacy, such as statin. Some studies indicated its association with vascular events, but no long-term, large-scale, prospective study excluding cancer-bearing patients has been conducted. In the future, data must be further accumulated. Concerning carotid artery lesions, there are no data on the onset of asymptomatic lesions or prediction of treatment-related risks, and future studies may provide promising information.

Information related to the author
© 2018 The Japanese Society for Neuroendovascular Therapy

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
Previous article